Literature DB >> 1968133

Development of multiple sclerosis in patient on long-term sulfasalazine.

R Gold, L Kappos, T Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1968133     DOI： 10.1016/0140-6736(90)90239-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Authors:  Ippazio Cosimo Antonazzo; Emanuel Raschi; Luca Vignatelli; Elisa Baldin; Trond Riise; Roberto D'Alessandro; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

Review 2.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

3.  [Proteinase 3 (cANCA)-associated ulcerative colitis with possible inflammatory leukoencephalopathic CNS involvement].

Authors:  Mosche Pompsch; Claudia Veltkamp; Roland Veltkamp; Ralph Weber
Journal:  Nervenarzt       Date:  2020-08       Impact factor: 1.214

4.  Crohn's disease and multiple sclerosis: a single case report.

Authors:  G P Buccino; G Corrente; D Visintini
Journal:  Ital J Neurol Sci       Date:  1994-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.